This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klag, M. J. Articles by Appel, L. J. Search for Related Content PubMed PubMed Citation Articles by Klag, M. J. Articles by Appel, L. J.

Hypertension, Vol 16, 700-705, Copyright © 1990 by American Heart Association

ARTICLES

Effect of age on the efficacy of blood pressure treatment strategies

MJ Klag, PK Whelton and LJ Appel
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.

To study whether the proportion of excess cardiovascular events attributable to various levels of systolic blood pressure varies with age, we calculated the population-attributable risk of all-cause mortality, fatal and nonfatal cardiovascular events (stroke, coronary heart disease, angina, congestive heart failure, and peripheral vascular disease), and stroke incidence due to systolic blood pressure in men and women 45 years of age or older in the United States during 1980. Our estimates are based on US census counts, blood pressure prevalence distributions from the second National Health and Nutrition Examination Survey, and the annual risk of cardiovascular complications during 18 years of follow-up in the Framingham cohort. We then determined the impact of age on the relative efficacy of mass treatment and case-finding strategies in preventing systolic blood pressure- related events. At 45-54 years of age, only 30-40% of systolic blood pressure-related excess events occur in hypertensive individuals (systolic blood pressure greater than or equal to 160 mm Hg). With increasing age, however, the percentage of systolic blood pressure- related events that occur in hypertensive individuals rose substantially; in the older age group (greater than or equal to 75 years), 65-70% of fatal and nonfatal cardiovascular disease events occur in hypertensive persons. The pattern is similar for men and women. The potential impact of a mass treatment strategy designed to shift the distribution of blood pressure downward by a small amount is greater in younger than in older groups, whereas an opposite trend is seen for a high-risk, hypertensive case-finding and treatment approach.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. H. Lichtenstein, L. J. Appel, M. Brands, M. Carnethon, S. Daniels, H. A. Franch, B. Franklin, P. Kris-Etherton, W. S. Harris, B. Howard, et al. Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006 Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2186 - 2191. [Full Text] [PDF]

				A. H. Lichtenstein, L. J. Appel, M. Brands, M. Carnethon, S. Daniels, H. A. Franch, B. Franklin, P. Kris-Etherton, W. S. Harris, B. Howard, et al. Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee Circulation, July 4, 2006; 114(1): 82 - 96. [Abstract] [Full Text] [PDF]

				L. J. Appel, M. W. Brands, S. R. Daniels, N. Karanja, P. J. Elmer, and F. M. Sacks Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association Hypertension, February 1, 2006; 47(2): 296 - 308. [Abstract] [Full Text] [PDF]

				Y. M. Ruigrok, E. Buskens, and G. J. E. Rinkel Attributable Risk of Common and Rare Determinants of Subarachnoid Hemorrhage Stroke, May 1, 2001; 32(5): 1173 - 1175. [Abstract] [Full Text] [PDF]

				T. R. Hartley, B. H. Sung, G. A. Pincomb, T. L. Whitsett, M. F. Wilson, and W. R. Lovallo Hypertension Risk Status and Effect of Caffeine on Blood Pressure Hypertension, July 1, 2000; 36(1): 137 - 141. [Abstract] [Full Text] [PDF]

				S. H. Jee, J. He, P. K. Whelton, I. Suh, and M. J. Klag The Effect of Chronic Coffee Drinking on Blood Pressure : A Meta-Analysis of Controlled Clinical Trials Hypertension, February 1, 1999; 33(2): 647 - 652. [Abstract] [Full Text] [PDF]

				P. K. Whelton, J. He, J. A. Cutler, F. L. Brancati, L. J. Appel, D. Follmann, and M. J. Klag Effects of Oral Potassium on Blood Pressure: Meta-analysis of Randomized Controlled Clinical Trials JAMA, May 28, 1997; 277(20): 1624 - 1632. [Abstract] [PDF]

				T. V. Perneger, M. J. Klag, H. I. Feldman, and P. K. Whelton Projections of Hypertension-Related Renal Disease in Middle-aged Residents of the United States JAMA, March 10, 1993; 269(10): 1272 - 1277. [Abstract] [PDF]